Rehmann Capital Advisory Group’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $750K | Buy |
8,649
+795
| +10% | +$76.2K | 0.04% | 303 |
|
|
2025
Q4 | $755K | Sell |
7,854
-1,222
| -13% | -$119K | 0.04% | 300 |
|
|
2025
Q3 | $859K | Sell |
9,076
-668
| -7% | -$61.4K | 0.05% | 259 |
|
|
2025
Q2 | $849K | Sell |
9,744
-2,649
| -21% | -$225K | 0.05% | 246 |
|
|
2025
Q1 | $1.11M | Sell |
12,393
-2,612
| -17% | -$234K | 0.07% | 206 |
|
|
2024
Q4 | $1.2M | Sell |
15,005
-178
| -1% | -$15.4K | 0.08% | 192 |
|
|
2024
Q3 | $1.38M | Sell |
15,183
-1,086
| -7% | -$91.4K | 0.09% | 166 |
|
|
2024
Q2 | $1.28M | Buy |
16,269
+282
| +2% | +$23.1K | 0.09% | 171 |
|
|
2024
Q1 | $1.39M | Sell |
15,987
-757
| -5% | -$64.6K | 0.1% | 154 |
|
|
2023
Q4 | $1.38M | Sell |
16,744
-1,605
| -9% | -$122K | 0.11% | 144 |
|
|
2023
Q3 | $1.44M | Buy |
18,349
+2,588
| +16% | +$217K | 0.13% | 123 |
|
|
2023
Q2 | $1.39M | Sell |
15,761
-1,909
| -11% | -$164K | 0.12% | 133 |
|
|
2023
Q1 | $1.42M | Buy |
17,670
+867
| +5% | +$70.7K | 0.13% | 129 |
|
|
2022
Q4 | $1.31M | Buy |
16,803
+7,818
| +87% | +$634K | 0.13% | 137 |
|
|
2022
Q3 | $726K | Buy |
8,985
+1,362
| +18% | +$122K | 0.08% | 219 |
|
|
2022
Q2 | $684K | Sell |
7,623
-571
| -7% | -$57.9K | 0.08% | 225 |
|
|
2022
Q1 | $909K | Buy |
8,194
+257
| +3% | +$27.2K | 0.09% | 198 |
|
|
2021
Q4 | $821K | Sell |
7,937
-260
| -3% | -$30.1K | 0.08% | 228 |
|
|
2021
Q3 | $1.03M | Sell |
8,197
-171
| -2% | -$22.1K | 0.1% | 181 |
|
|
2021
Q2 | $1.04M | Sell |
8,368
-745
| -8% | -$93.5K | 0.1% | 176 |
|
|
2021
Q1 | $1.08M | Buy |
9,113
+560
| +7% | +$65.6K | 0.11% | 156 |
|
|
2020
Q4 | $1M | Sell |
8,553
-351
| -4% | -$38.6K | 0.11% | 152 |
|
|
2020
Q3 | $926K | Buy |
8,904
+45
| +0.5% | +$4.52K | 0.12% | 154 |
|
|
2020
Q2 | $815K | Buy |
8,859
+782
| +10% | +$75K | 0.11% | 160 |
|
|
2020
Q1 | $729K | Buy |
+8,077
| New | +$859K | 0.12% | 145 |
|
|
2019
Q3 | $857K | Buy |
7,887
+1,914
| +32% | +$200K | 0.1% | 104 |
|
|
2019
Q2 | $582K | Buy |
5,973
+493
| +9% | +$45K | 0.07% | 222 |
|
|
2019
Q1 | $499K | Sell |
5,480
-387
| -7% | -$34.6K | 0.07% | 219 |
|
|
2018
Q4 | $534K | Sell |
5,867
-21
| -0.4% | -$1.96K | 0.08% | 131 |
|
|
2018
Q3 | $579K | Sell |
5,888
-3,670
| -38% | -$339K | 0.08% | 198 |
|
|
2018
Q2 | $502K | Buy |
9,558
+2,939
| +44% | +$245K | 0.07% | 204 |
|
|
2018
Q1 | $531K | Sell |
6,619
-277
| -4% | -$22.8K | 0.08% | 183 |
|
|
2017
Q4 | $557K | Sell |
6,896
-617
| -8% | -$49.4K | 0.09% | 180 |
|
|
2017
Q3 | $584K | Buy |
7,513
+358
| +5% | +$29.7K | 0.11% | 171 |
|
|
2017
Q2 | $635K | Sell |
7,155
-412
| -5% | -$34.7K | 0.12% | 147 |
|
|
2017
Q1 | $610K | Buy |
7,567
+1,244
| +20% | +$97.2K | 0.1% | 169 |
|
|
2016
Q4 | $450K | Buy |
6,323
+719
| +13% | +$56.5K | 0.08% | 208 |
|
|
2016
Q3 | $484K | Sell |
5,604
-721
| -11% | -$62.8K | 0.09% | 182 |
|
|
2016
Q2 | $549K | Sell |
6,325
-276
| -4% | -$22.3K | 0.1% | 163 |
|
|
2016
Q1 | $495K | Sell |
6,601
-296
| -4% | -$22.3K | 0.1% | 170 |
|
|
2015
Q4 | $531K | Buy |
6,897
+823
| +14% | +$62K | 0.11% | 151 |
|
|
2015
Q3 | $407K | Sell |
6,074
-225
| -4% | -$16.6K | 0.09% | 170 |
|
|
2015
Q2 | $467K | Sell |
6,299
-913
| -13% | -$69.8K | 0.11% | 163 |
|
|
2015
Q1 | $562K | Buy |
+7,212
| New | +$547K | 0.13% | 146 |
|
Other funds holding MDT
VCM
VPM
Rehmann Capital Advisory Group's MDT Position: Q1 2026 in Review
Rehmann Capital Advisory Group increased its Medtronic (MDT) stake by 10% in Q1 2026, buying an estimated $76.2K and bringing the position to 8,649 shares worth $750K. The position accounts for 0.04% of the portfolio, ranked #303.
Rehmann Capital Advisory Group first reported a position in MDT in Q1 2015 and has held it in 44 quarters since. The position peaked at $1.44M in Q3 2023. 2,231 funds tracked by Wall St. Rank hold MDT as of Q1 2026.
- Rehmann Capital Advisory Group held 8,649 shares of Medtronic worth $750K as of Q1 2026.
- Rehmann Capital Advisory Group bought 795 Medtronic shares in Q1 2026, an estimated $76.2K.
- Medtronic made up 0.04% of Rehmann Capital Advisory Group's portfolio in Q1 2026, its #303 holding.
- Rehmann Capital Advisory Group first reported a position in Medtronic in Q1 2015 and has held it in 44 quarters since.
- Rehmann Capital Advisory Group's Medtronic position peaked at $1.44M in Q3 2023.
- 2,231 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.
Based on Rehmann Capital Advisory Group's 13F filing for Q1 2026, filed 15 May 2026.